Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01981772 · ClinicalTrials.gov registry record · NA
Efficacy of Buffered Lidocaine in Patients With Facial Swelling
A NA study, sponsored by Ohio State University.
- Completed
- Registry status
- NA
- Development phase
- 88
- Enrollment target
NCT01981772 is a NA study that has completed, run by Ohio State University. The registered enrollment target is 88 participants.
The verdict
NCT01981772, a NA study, has completed, sponsored by Ohio State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 88 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the clinical efficacy of a buffered 4% lidocaine solution for incision and drainage. Ninety patients will be examined clinically to determine a diagnosis of cellulitis or fluctuance. The diagnosis will be confirmed by incision and drainage. Patients will receive either 3.6 ml 4% lidocaine with 1:100,000 epinephrine or 3.6 ml 4% lidocaine with 1:100,000 epinephrine buffered with 8.4% sodium bicarbonate. Patients will rate pain prior to and throughout the procedure.
Interventions
- DRUG 4% lidocaine with 1:100,000 epinephrine
- DRUG 4% buffered lidocaine with 1:100,000 epinephrine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 88 participants |
| Start Date | 2013-03 |
| Est. Completion | 2014-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01981772
The ClinicalTrials.gov registry entry for NCT01981772 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 88 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ohio State University, which has 552 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which 4% lidocaine with 1:100,000 epinephrine is the first listed.
NCT01981772 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01981772 about?
NCT01981772 is a clinical study titled "Efficacy of Buffered Lidocaine in Patients With Facial Swelling". The purpose of this study is to determine the clinical efficacy of a buffered 4% lidocaine solution for incision and drainage. Ninety patients will be examined clinically to determine a diagnosis of cellulitis or fluctuance. The diagnosis will be confirmed by incision and drainage. Patients will rec...
What is the current status of trial NCT01981772?
This trial is currently completed. It is a NA study. The enrollment target is 88 participants. The study started on 2013-03. Estimated completion is 2014-06.
What interventions are being tested in trial NCT01981772?
The interventions under investigation include: 4% lidocaine with 1:100,000 epinephrine (DRUG), 4% buffered lidocaine with 1:100,000 epinephrine (DRUG).
Who is sponsoring clinical trial NCT01981772?
This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.